Moneycontrol PRO
Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/-, exclusive for Moneycontrol Pro subscribers. Register now!
you are here: HomeNewsWorld

Australia to spend $726 million underwriting country's biggest vaccine plant

Under the deal, CSL vaccine subsidiary Seqirus would spend A$800 million building the facility in the city of Melbourne

November 16, 2020 / 10:47 PM IST

Australia will spend A$1 billion ($726.3 million) underwriting construction of a vaccine manufacturing plant under a deal with a unit of biomedical giant CSL Ltd, guaranteeing the supply of flu shots and antivenins, the federal government said on Monday.


Under the deal, CSL vaccine subsidiary Seqirus would spend A$800 million building the facility in the city of Melbourne, while the government would guarantee purchase of its vaccines for 10 years, local media reported.


The purchase agreement would begin when the new plant opens in 2026, in time for the expiry of a current supply agreement with CSL which runs until about 2025, media added.


Click here for latest updates on coronavirus pandemic


“We’re currently well placed, but we want to be even better placed because who knows what will come,” Health Minister Greg Hunt told the Australian Broadcasting Corp.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“We’ll have that national vaccine manufacturing capability as well as the long-term contracts for flu and for anti-venoms.”


Hunt added the new CSL plant would be the largest vaccine manufacturing plant in the southern hemisphere.


The Australian government has already struck agreements with CSL to supply two potential vaccines for the new coronavirus which are being trialled by Britain’s AstraZeneca Plc and the Australia’s University of Queensland.

Click here for Moneycontrol's full coverage of the COVID-19 outbreak



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

Reuters
first published: Nov 16, 2020 11:38 am
Sections
ISO 27001 - BSI Assurance Mark